Stay updated on ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The Publications section now notes that publications are automatically filled from PubMed and displays Revision: v3.3.2. The previous wording indicating PubMed publications were provided directly (Revision: v3.2.0) was removed.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:09.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The government funding/operating status notice has been removed from the page. This change does not affect the core study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:20:04.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The new screenshot shows minor layout adjustments to the Study Details page, with slight rearrangement of sections and updated visuals, but the core study information remains the same.
    Difference
    0.2%
    Check dated 2025-11-03T21:22:49.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    3%
    Check dated 2025-10-06T06:59:35.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:44:01.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Page revision now shows v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed as a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T21:25:29.000Z thumbnail image

Stay in the know with updates to ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page.